NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors

NCT00299728 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Tumors

Interventions

BIOLOGICAL: NY-ESO-1 Protein Vaccine

Sponsor

Ludwig Institute for Cancer Research

Collaborators

[object Object]